TransEnterix Shares Make New 52-Week High of $5, Now Up ~63.7% At $4.60; Co. Earlier Reported in 8-K Filing That Recent FDA Clearance For Senhance Surgical Robotic System Had Triggered Accelerated Expiration Date For Warrants To Purchase Common Stock